Cantor Fitzgerald analyst Steven Halper noted that new documents were posted on Wednesday concerning the pending FTC lawsuit against Simple Health and Steve Dorfman. He also noted that investors recently have been concerned about Health Insurance Innovations' past relationship with Simple and Dorfman. In his view, the documents validate his opinion that the FTC process should not impact Health Insurance Innovations "at all" and the process should put to rest the ongoing concerns. Halper, who thinks Health Insurance Innovations shares "remain compelling by any measure," keeps an Overweight rating on the stock.